(Q42218306)

18 October 2017

Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia (English)

1 reference

18 October 2017

S C Hammill

1

1 reference

18 October 2017

C J McLaran

2

1 reference

18 October 2017

D L Wood

3

1 reference

18 October 2017

M J Osborn

4

1 reference

18 October 2017

B J Gersh

5

1 reference

18 October 2017

D R Holmes

6

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 June 1987

1 reference

Journal of the American College of Cardiology

18 October 2017

1 reference

18 October 2017

9

1 reference

18 October 2017

6

1 reference

18 October 2017

1364-1368

1 reference

Antiarrhythmic and electrophysiologic effects of oral propafenone

18 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

Electrophysiological effects of propafenone studied with programmed electrical stimulation of the heart in patients with recurrent paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

Effects of Propafenone on Induction and Maintenance of Atrioventricular Nodal Reentrant Tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

Propafenone for the treatment of refractory complex ventricular ectopic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

Electrophysiologic testing in the upright position: improved evaluation of patients with rhythm disturbances using a tilt table

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

Clinical pharmacology of propafenone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

The multiple modes of action of propafenone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

1 reference

7 January 2021

Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980479-5

7 January 2021

10.1016/S0735-1097(87)80479-5

Identifiers

DOI

1 reference

18 October 2017

1 reference